Cargando…
Acute Liver Injury after CCl(4) Administration Is Independent of Smad7 Expression in Myeloid Cells
Myeloid cells are essential for the initiation and termination of innate and adaptive immunity that create homeostasis in the liver. Smad7 is an inhibitor of the transforming growth factor β (TGF-β) signaling pathway, which regulates inflammatory cellular processes. Knockdown of Smad7 in hepatocytes...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888233/ https://www.ncbi.nlm.nih.gov/pubmed/31698731 http://dx.doi.org/10.3390/ijms20225528 |
_version_ | 1783475181836042240 |
---|---|
author | Endig, Jessica Unrau, Ludmilla Sprezyna, Paulina Rading, Sebasting Karsak, Meliha Goltz, Diane Heukamp, Lukas C. Tiegs, Gisa Diehl, Linda |
author_facet | Endig, Jessica Unrau, Ludmilla Sprezyna, Paulina Rading, Sebasting Karsak, Meliha Goltz, Diane Heukamp, Lukas C. Tiegs, Gisa Diehl, Linda |
author_sort | Endig, Jessica |
collection | PubMed |
description | Myeloid cells are essential for the initiation and termination of innate and adaptive immunity that create homeostasis in the liver. Smad7 is an inhibitor of the transforming growth factor β (TGF-β) signaling pathway, which regulates inflammatory cellular processes. Knockdown of Smad7 in hepatocytes has been shown to promote liver fibrosis, but little is known about the effects of Smad7 in myeloid cells during inflammatory responses in the liver. Using mice with a myeloid-specific knockdown of Smad7 (LysM-Cre Smad7(fl/fl)), we investigated the impact of Smad7 deficiency in myeloid cells on liver inflammation and regeneration using the well-established model of CCl(4)-mediated liver injury. Early (24/48 h) and late (7 d) time points were analyzed. We found that CCl(4) induces severe liver injury, with elevated serum ALT levels, centrilobular and periportal necrosis, infiltrating myeloid cells and an increase of inflammatory cytokines in the liver. Furthermore, as expected, inflammation peaked at 24 h and subsided after 7 d. However, the knockdown of Smad7 in myeloid cells did not affect any of the investigated parameters in the CCl(4)-treated animals. In summary, our results suggest that the inhibition of TGF-β signaling via Smad7 expression in myeloid cells is dispensable for the induction and control of acute CCl(4)-induced liver injury. |
format | Online Article Text |
id | pubmed-6888233 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-68882332019-12-09 Acute Liver Injury after CCl(4) Administration Is Independent of Smad7 Expression in Myeloid Cells Endig, Jessica Unrau, Ludmilla Sprezyna, Paulina Rading, Sebasting Karsak, Meliha Goltz, Diane Heukamp, Lukas C. Tiegs, Gisa Diehl, Linda Int J Mol Sci Article Myeloid cells are essential for the initiation and termination of innate and adaptive immunity that create homeostasis in the liver. Smad7 is an inhibitor of the transforming growth factor β (TGF-β) signaling pathway, which regulates inflammatory cellular processes. Knockdown of Smad7 in hepatocytes has been shown to promote liver fibrosis, but little is known about the effects of Smad7 in myeloid cells during inflammatory responses in the liver. Using mice with a myeloid-specific knockdown of Smad7 (LysM-Cre Smad7(fl/fl)), we investigated the impact of Smad7 deficiency in myeloid cells on liver inflammation and regeneration using the well-established model of CCl(4)-mediated liver injury. Early (24/48 h) and late (7 d) time points were analyzed. We found that CCl(4) induces severe liver injury, with elevated serum ALT levels, centrilobular and periportal necrosis, infiltrating myeloid cells and an increase of inflammatory cytokines in the liver. Furthermore, as expected, inflammation peaked at 24 h and subsided after 7 d. However, the knockdown of Smad7 in myeloid cells did not affect any of the investigated parameters in the CCl(4)-treated animals. In summary, our results suggest that the inhibition of TGF-β signaling via Smad7 expression in myeloid cells is dispensable for the induction and control of acute CCl(4)-induced liver injury. MDPI 2019-11-06 /pmc/articles/PMC6888233/ /pubmed/31698731 http://dx.doi.org/10.3390/ijms20225528 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Endig, Jessica Unrau, Ludmilla Sprezyna, Paulina Rading, Sebasting Karsak, Meliha Goltz, Diane Heukamp, Lukas C. Tiegs, Gisa Diehl, Linda Acute Liver Injury after CCl(4) Administration Is Independent of Smad7 Expression in Myeloid Cells |
title | Acute Liver Injury after CCl(4) Administration Is Independent of Smad7 Expression in Myeloid Cells |
title_full | Acute Liver Injury after CCl(4) Administration Is Independent of Smad7 Expression in Myeloid Cells |
title_fullStr | Acute Liver Injury after CCl(4) Administration Is Independent of Smad7 Expression in Myeloid Cells |
title_full_unstemmed | Acute Liver Injury after CCl(4) Administration Is Independent of Smad7 Expression in Myeloid Cells |
title_short | Acute Liver Injury after CCl(4) Administration Is Independent of Smad7 Expression in Myeloid Cells |
title_sort | acute liver injury after ccl(4) administration is independent of smad7 expression in myeloid cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888233/ https://www.ncbi.nlm.nih.gov/pubmed/31698731 http://dx.doi.org/10.3390/ijms20225528 |
work_keys_str_mv | AT endigjessica acuteliverinjuryafterccl4administrationisindependentofsmad7expressioninmyeloidcells AT unrauludmilla acuteliverinjuryafterccl4administrationisindependentofsmad7expressioninmyeloidcells AT sprezynapaulina acuteliverinjuryafterccl4administrationisindependentofsmad7expressioninmyeloidcells AT radingsebasting acuteliverinjuryafterccl4administrationisindependentofsmad7expressioninmyeloidcells AT karsakmeliha acuteliverinjuryafterccl4administrationisindependentofsmad7expressioninmyeloidcells AT goltzdiane acuteliverinjuryafterccl4administrationisindependentofsmad7expressioninmyeloidcells AT heukamplukasc acuteliverinjuryafterccl4administrationisindependentofsmad7expressioninmyeloidcells AT tiegsgisa acuteliverinjuryafterccl4administrationisindependentofsmad7expressioninmyeloidcells AT diehllinda acuteliverinjuryafterccl4administrationisindependentofsmad7expressioninmyeloidcells |